Janson C, Herala M
Department of Lung Medicine, Uppsala University, Akademiska sjukhuset, Sweden.
Ann Allergy. 1993 May;70(5):400-4.
This investigation comprised 58 patients (35 men, mean age 61 years) with acute asthma: mean FEV1 35% of the predicted. The dyspnea score (Borg's scale), breathing rate, pulse rate, blood pressure, FEV1, and PEF were measured on arrival and 30, 60, and 150 minutes after bronchodilator treatment. The level of clinical severity was evaluated using Hedstrand's asthma severity scale. The variables that correlated most closely with dyspnea score at arrival were asthma severity score (r = .51 P < .001) and breathing rate (r = .38, P < .01). The measurement of airflow obstruction with the closest correlation to improvement in dyspnea was FEV1 expressed as a percentage of the pretreatment value (r = -.30* after 30 min, r = -.42** after 60 and r = -.34* after 150 minutes, *P < .05, **P < .01). When examining the intraindividual correlation between the change in dyspnea score and FEV1, a correlation coefficient of more than 0.80 was found in 74% of the patients. Of 18 patients with an increase in FEV1 of less than 20% of baseline, 11 had a decrease in dyspnea score in 3 or more categories. We conclude that there is a discrepancy in the treatment of acute asthma between the effect on dyspnea and airflow obstruction, the clinical implication of which remains to be investigated.
本研究纳入了58例急性哮喘患者(35例男性,平均年龄61岁):平均第一秒用力呼气容积(FEV1)为预测值的35%。在患者到达时以及支气管扩张剂治疗后30、60和150分钟测量呼吸困难评分(Borg量表)、呼吸频率、脉搏率、血压、FEV1和呼气峰值流速(PEF)。使用赫德斯特兰德哮喘严重程度量表评估临床严重程度水平。到达时与呼吸困难评分相关性最密切的变量是哮喘严重程度评分(r = 0.51,P < 0.001)和呼吸频率(r = 0.38,P < 0.01)。与呼吸困难改善相关性最密切的气流阻塞测量指标是以治疗前值的百分比表示的FEV1(30分钟后r = -0.30*,60分钟后r = -0.42**,150分钟后r = -0.34*,*P < 0.05,**P < 0.01)。在检查呼吸困难评分变化与FEV1之间的个体内相关性时,74%的患者相关系数超过0.80。在18例FEV1增加小于基线值20%的患者中,11例呼吸困难评分下降了3个或更多等级。我们得出结论,急性哮喘治疗中对呼吸困难和气流阻塞的影响存在差异,其临床意义仍有待研究。